Intra Cellular Therapies Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 4.62, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Intra Cellular Therapies Inc in Dec 31 2024 quarter, has decreased to 79 days, compared to 80 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 396 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 2692 to 2884.

What is Receivable Turnover Ratio?
What is Intra Cellular Therapies Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ITCI Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	46.03 %	41.82 %	51.84 %	60.84 %	51.64 %
Y / Y Revenue Change	50.81 %	39 %	45.67 %	52 %	50.34 %
Receivable Turnover Ratio (TTM)	4.62	4.58	4.58	4.63	4.71
ITCI's Total Ranking	# 2884	# 2692	# 901	# 571	# 2322
Accounts Receivable average collection period days	79	80	80	79	77
Seq. Receivable Change	14.35 %	-0.07 %	11.1 %	15.03 %	11.05 %
Seq. Revenue Change	13.6 %	8.67 %	11.41 %	9.66 %	4.7 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 116
Healthcare Sector	# 397
Overall Market	# 2884

Receivable Turnover Ratio Statistics
High	Average	Low
7.21	4.78	3.73
(Dec 31 2017)		(Sep 30 2020)

ITCI Company Profile • Back to ITCI Efficiency Comparisons • Compare ITCI Receivables Turnover Ratio to its Competitors

Financial Statements
Intra Cellular Therapies Inc 's Accounts Receivable	$ 167 Millions	Visit ITCI's Balance sheet
Intra Cellular Therapies Inc 's Sales TTM	$ 681 Millions	Visit ITCI's Income Statement
Sources of ITCI's Revenues		Visit ITCI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ITCI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ITCI's Growth Rates	ITCI's Roa	ITCI's Inventory Turnover Ratio	ITCI's Dividend Comparisons
ITCI's Profitability Ratios	ITCI's Roi	ITCI's Asset Turnover Ratio	ITCI's Dividend Growth
ITCI's Valuation Ratios	ITCI's Roe	ITCI's Financial Strength Ratios	ITCI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Concentra Group Holdings Parent Inc	11.20	$ 1,900.192 Millions	$ 169.721 Millions
Longeveron Inc	11.13	$ 2.392 Millions	$ 0.215 Millions
Exact Sciences Corporation	10.95	$ 2,788.463 Millions	$ 254.559 Millions
Myomo Inc	10.94	$ 32.185 Millions	$ 2.941 Millions
Newamsterdam Pharma Company N v	10.88	$ 45.563 Millions	$ 4.188 Millions
Zomedica Corp	10.84	$ 27.087 Millions	$ 2.499 Millions
Clene Inc	10.69	$ 0.342 Millions	$ 0.032 Millions
Addus Homecare Corp	10.65	$ 1,154.021 Millions	$ 108.350 Millions
Utah Medical Products Inc	10.65	$ 40.126 Millions	$ 3.768 Millions
Option Care Health Inc	10.63	$ 4,998.202 Millions	$ 470.159 Millions
Novavax inc	10.63	$ 682.162 Millions	$ 64.183 Millions
Sanuwave Health Inc	10.59	$ 32.634 Millions	$ 3.082 Millions
National Healthcare Corp	10.43	$ 1,307.382 Millions	$ 125.362 Millions
Sunlink Health Systems Inc	10.39	$ 31.927 Millions	$ 3.073 Millions
Rockwell Medical inc	10.38	$ 101.484 Millions	$ 9.778 Millions
Lftd Partners Inc	10.34	$ 37.325 Millions	$ 3.611 Millions
Equillium Inc	10.31	$ 41.095 Millions	$ 3.988 Millions
Strata Critical Medical Inc	10.22	$ 248.693 Millions	$ 24.336 Millions
Fractyl Health Inc	10.05	$ 0.093 Millions	$ 0.009 Millions
Sunshine Biopharma Inc	10.04	$ 34.874 Millions	$ 3.472 Millions
Beyond Air Inc	10.02	$ 4.527 Millions	$ 0.452 Millions
Quidelortho Corp	9.95	$ 2,782.900 Millions	$ 279.625 Millions
Immucell Corporation	9.95	$ 26.493 Millions	$ 2.663 Millions
Lensar Inc	9.82	$ 53.494 Millions	$ 5.447 Millions
Neurometrix Inc	9.81	$ 2.680 Millions	$ 0.273 Millions
Dih Holding Us Inc	9.79	$ 112.019 Millions	$ 11.440 Millions
Nexgel Inc	9.77	$ 7.748 Millions	$ 0.793 Millions
Lipella Pharmaceuticals Inc	9.75	$ 0.536 Millions	$ 0.055 Millions
Biontech Se	9.71	$ 3,081.232 Millions	$ 317.296 Millions
Escalon Medical Corp	9.60	$ 12.169 Millions	$ 1.268 Millions

Date modified: 2026-06-22T16:30:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.